0
0
BOSTON, MA – A new study published in the January 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation has revealed potential impacts of common medications on muscle health in current and former smokers. Researchers found that statin use may be associated with reduced chest muscle loss, while aspirin use may contribute to increased chest muscle loss in this population.
The study, led by Dr. Toru Shirahata, a pulmonologist at Brigham and Women’s Hospital and Harvard Medical School, analyzed chest CT imaging data from the COPD Genetic Epidemiology (COPDGene) study, involving 4,191 participants. These individuals, all current or former smokers, had reported medication usage and underwent chest CT scans during both phase 1 and phase 2 of the COPDGene study.
Smokers, especially those with Chronic Obstructive Pulmonary Disease (COPD), a progressive lung disease, are known to experience accelerated skeletal muscle loss. Given that many current and former smokers are prescribed statins for cholesterol management and aspirin for heart disease prevention, the researchers aimed to investigate the effects of these medications on pectoralis muscle area and density.
“Current and former smokers have a higher risk of cardiovascular disease and diabetes and are commonly prescribed statins and aspirin to treat these conditions,” Dr. Shirahata explained. “By examining the impact of these medications on pectoralis muscle area and density, we found that statins can potentially reduce chest muscle loss, while aspirin may contribute to increased chest muscle loss.”
COPD, which includes conditions like chronic bronchitis and emphysema, affects over 30 million Americans and is a leading cause of death worldwide. The disease is often linked to smoking and other irritants.
The researchers believe that their findings could lead to more personalized treatment plans for smokers. “By further examining the impact of statins and aspirin on skeletal muscle mass, health care providers may be able to better personalize treatments to improve outcomes for these patients,” Dr. Shirahata stated.
The study utilized chest CT imaging to measure changes in pectoralis muscle area and density over time, providing valuable insights into the potential effects of these commonly prescribed medications.
The research was published under the title “Effect of Common Medications on Longitudinal Pectoralis Muscle Area in Smokers” with DOI: 10.15326/jcopdf.2024.0557.
Disclaimer: This news article is based on the provided information and is intended for informational purposes only. The findings of this study do not constitute medical advice. Individuals should consult with their healthcare providers before making any changes to their medication regimen or treatment plans. Further research is needed to confirm these findings and understand the underlying mechanisms.
